Lymphoid tissue structure and HIV-1 infection: life or death for T cells.

Secondary lymphoid tissue (LT) structure facilitates immune responses and maintains homeostasis of T cells through production of survival factors, such as interleukin (IL)-7 that is 'posted' on the stromal fibroblastic reticular cell (FRC) network on which T cells traffic. Here, we examine the pathological changes that occur in LTs during HIV and simian immunodeficiency virus (SIV) infection. Immune activation leads to collagen deposition and loss of the FRC network itself. This decreases access to IL-7 and reduces the major source of IL-7, both of which deplete naïve T cells to limit immune reconstitution with antiretroviral treatment. We discuss the implications of LT structure damage for the timing of antiretroviral therapy and consider the development of adjunctive antifibrotic agents to improve immune reconstitution in HIV infection.

[1]  J. Carlis,et al.  Simian immunodeficiency virus-induced lymphatic tissue fibrosis is mediated by transforming growth factor beta 1-positive regulatory T cells and begins in early infection. , 2007, The Journal of infectious diseases.

[2]  Steven Wolinsky,et al.  Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy. , 2002, The Journal of infectious diseases.

[3]  S. Jameson,et al.  Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo , 2000, Nature Immunology.

[4]  A. Haase,et al.  Collagen deposition limits immune reconstitution in the gut. , 2008, The Journal of infectious diseases.

[5]  Richard D Moore,et al.  CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  B. Haynes,et al.  The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. , 2000, Annual review of immunology.

[7]  Richard Murray,et al.  IL-7 is critical for homeostatic proliferation and survival of naïve T cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Kremmer,et al.  Lymph node T cell homeostasis relies on steady state homing of dendritic cells. , 2011, Immunity.

[9]  A. Haase,et al.  Lymphoid Tissue Damage in HIV-1 Infection Depletes Naïve T Cells and Limits T Cell Reconstitution after Antiretroviral Therapy , 2012, PLoS pathogens.

[10]  J. Palefsky,et al.  High Prevalence of Anal Squamous Intraepithelial Lesions in HIV-Positive Men Despite the Use of Highly Active Antiretroviral Therapy , 2004, Sexually transmitted diseases.

[11]  A. Wald,et al.  Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy. , 2004, The Journal of infectious diseases.

[12]  Rob J. De Boer,et al.  Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation , 1998, Nature Medicine.

[13]  J. Sprent,et al.  T cell homeostasis , 2008, Immunology and cell biology.

[14]  O. Kirk,et al.  Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. , 2006, Archives of internal medicine.

[15]  C. Thompson,et al.  IL-7 Enhances the Survival and Maintains the Size of Naive T Cells1 , 2001, The Journal of Immunology.

[16]  Jeffrey N. Martin,et al.  Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  N. Kaminski,et al.  The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. , 1999, Cell.

[18]  R. Koup,et al.  T cell dynamics in HIV-1 infection. , 2003, Annual review of immunology.

[19]  A. Phillips,et al.  The role of HIV in serious diseases other than AIDS , 2008, AIDS.

[20]  M. Saag,et al.  Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. , 1999, The Journal of clinical investigation.

[21]  E. Kaldjian,et al.  Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. , 2001, International immunology.

[22]  Paul Palumbo,et al.  Measuring Recent Thymic Emigrants in Blood of Normal and HIV-1–Infected Individuals before and after Effective Therapy , 1999, The Journal of experimental medicine.

[23]  D. Douek,et al.  IL-7 therapy dramatically alters peripheral T-cell homeostasis in normal and SIV-infected nonhuman primates. , 2003, Blood.

[24]  D. Lacey,et al.  Protection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantation. , 2002, Blood.

[25]  L. Williams,et al.  Mice Lacking Expression of Secondary Lymphoid Organ Chemokine Have Defects in Lymphocyte Homing and Dendritic Cell Localization , 1999, The Journal of experimental medicine.

[26]  J. Sprent,et al.  Homeostatic proliferation and survival of naïve and memory T cells , 2009, European journal of immunology.

[27]  Stephen Shaw,et al.  Cords, channels, corridors and conduits: critical architectural elements facilitating cell interactions in the lymph node cortex , 1997, Immunological reviews.

[28]  A. Fauci,et al.  The immunopathogenesis of human immunodeficiency virus infection. , 1993, The New England journal of medicine.

[29]  E. Wolf,et al.  CCR7 Coordinates the Primary Immune Response by Establishing Functional Microenvironments in Secondary Lymphoid Organs , 1999, Cell.

[30]  Stephen Shaw,et al.  Lymph-Borne Chemokines and Other Low Molecular Weight Molecules Reach High Endothelial Venules via Specialized Conduits While a Functional Barrier Limits Access to the Lymphocyte Microenvironments in Lymph Node Cortex , 2000, The Journal of experimental medicine.

[31]  D. Watkins,et al.  Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. , 2006, The Journal of infectious diseases.

[32]  G. Bokoch,et al.  Sophisticated strategies for information encounter in the lymph node: the reticular network as a conduit of soluble information and a highway for cell traffic. , 1996, Journal of immunology.

[33]  S. Maiella,et al.  In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2–treated HIV patients , 2010, Proceedings of the National Academy of Sciences.

[34]  B. Haynes,et al.  The human thymus , 1998, Immunologic research.

[35]  H. Valdez Immune restoration after treatment of HIV-1 infection with highly active antiretroviral therapy (HAART). , 2002, AIDS reviews.

[36]  D. Musher,et al.  Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  Antonio Martínez,et al.  Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors. , 2011, The Journal of infectious diseases.

[38]  Bartlett,et al.  Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. , 1999, The Journal of clinical investigation.

[39]  B. Haynes,et al.  The human thymus , 1998 .

[40]  J. Angel,et al.  Interleukin-7 receptor expression on CD8(+) T cells is reduced in HIV infection and partially restored with effective antiretroviral therapy. , 2001, Journal of acquired immune deficiency syndromes.

[41]  Stephen R Cole,et al.  Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies , 2009, The Lancet.

[42]  M. Dybul,et al.  Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy. , 2009, The Journal of infectious diseases.

[43]  M. Kolb,et al.  Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. , 2005, American journal of respiratory and critical care medicine.

[44]  A. Haase,et al.  Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. , 1999, Annual review of immunology.

[45]  Louis J. Picker,et al.  Changes in thymic function with age and during the treatment of HIV infection , 1998, Nature.

[46]  W. K. Henry,et al.  CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection , 2008, AIDS.

[47]  M. Zupancic,et al.  Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Lederman,et al.  Disease-Modifying Therapeutic Concepts for HIV in the Era of Highly Active Antiretroviral Therapy , 2011, Journal of acquired immune deficiency syndromes.

[49]  K. Camphausen,et al.  Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques. , 2007, Blood.

[50]  J. Metcalf,et al.  Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults , 1998, Nature Medicine.

[51]  C. Ware,et al.  Lymphotoxin alphabeta is expressed on recently activated naive and Th1-like CD4 cells but is down-regulated by IL-4 during Th2 differentiation. , 1999, Journal of immunology.

[52]  C. Rouzioux,et al.  Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. , 2009, The Journal of clinical investigation.

[53]  A. Ferrer,et al.  Bacterial pneumonia in HIV‐infected patients: use of the pneumonia severity index and impact of current management on incidence, aetiology and outcome , 2008, HIV medicine.

[54]  Mario Roederer,et al.  Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.

[55]  B. Hinz,et al.  Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells , 2007, Nature Immunology.

[56]  J. Girard,et al.  Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules , 2011, Nature.

[57]  F. Miedema,et al.  Maintenance of peripheral naive T cells is sustained by thymus output in mice but not humans. , 2012, Immunity.

[58]  H. Bang,et al.  Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. , 2010, The New England journal of medicine.

[59]  K. Miyazono,et al.  Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. , 1999, The Journal of clinical investigation.

[60]  D. Douek Disrupting T-cell homeostasis: how HIV-1 infection causes disease. , 2003, AIDS reviews.

[61]  Jeffrey N. Martin,et al.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy. , 2003, The Journal of infectious diseases.

[62]  Michael Sixt,et al.  The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.

[63]  R. Neiman,et al.  The Histologic Features of Hyperplastic Lymphadenopathy in AIDS-Related Complex are Nonspecific , 1987, The American journal of surgical pathology.

[64]  M. Kurimoto,et al.  Naive human CD4+ T cells are a major source of lymphotoxin alpha. , 1999, Journal of immunology.

[65]  Z. Grossman,et al.  Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[66]  S. Kaech,et al.  Generation of effector CD8+ T cells and their conversion to memory T cells , 2010, Immunological reviews.

[67]  J. Alimonti,et al.  IL‐7Rα expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation , 2006, European journal of immunology.

[68]  B. Gazzard,et al.  Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1. , 2003, Blood.

[69]  R. Desrosiers,et al.  Early Regeneration of Thymic Progenitors in Rhesus Macaques Infected with Simian Immunodeficiency Virus , 1998, The Journal of experimental medicine.

[70]  J. Sprent,et al.  Homeostasis of naive and memory T cells. , 2008, Immunity.

[71]  R. Shafer,et al.  Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[72]  M. Jenkins,et al.  CD4+ memory T cell survival. , 2011, Current opinion in immunology.

[73]  S. Pambuccian,et al.  Lymphatic Tissue Fibrosis Is Associated with Reduced Numbers of Naïve CD4+ T Cells in Human Immunodeficiency Virus Type 1 Infection , 2006, Clinical and Vaccine Immunology.

[74]  Ryung S. Kim,et al.  Limited immune restoration after 3 years’ suppression of HIV-1 replication in patients with moderately advanced disease , 2002, AIDS.

[75]  A. Moorman,et al.  Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  Ulrich H. von Andrian,et al.  Homing and cellular traffic in lymph nodes , 2003, Nature Reviews Immunology.

[77]  Kensuke Takada,et al.  Naive T cell homeostasis: from awareness of space to a sense of place , 2009, Nature Reviews Immunology.

[78]  S. Henrickson,et al.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.

[79]  Michael Proschan,et al.  Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals , 2007, Proceedings of the National Academy of Sciences.

[80]  R. Braun,et al.  Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. , 1997, Biochemical pharmacology.

[81]  Ruy M Ribeiro,et al.  Impact of thymectomy on the peripheral T cell pool in rhesus macaques before and after infection with simian immunodeficiency virus , 2005, European journal of immunology.

[82]  A. Haase,et al.  Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count , 2005, AIDS.

[83]  Peter Hunt,et al.  Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. , 2004, Blood.

[84]  Antonio Martínez,et al.  Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients , 2010, AIDS.

[85]  H. Lane,et al.  Interleukin-2 therapy in patients with HIV infection. , 2009, The New England journal of medicine.

[86]  T. Hara,et al.  Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes , 2004, The Journal of experimental medicine.

[87]  J. Flamm,et al.  Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.

[88]  J. Goedert,et al.  Cancer risk in people infected with human immunodeficiency virus in the United States , 2008, International journal of cancer.

[89]  A. Haase,et al.  The role of collagen deposition in depleting CD4+ T cells and limiting reconstitution in HIV-1 and SIV infections through damage to the secondary lymphoid organ niche. , 2008, Seminars in immunology.

[90]  R. Jenq,et al.  Interleukin-22 Drives Endogenous Thymic Regeneration in Mice , 2012, Science.

[91]  Takahiro Hara,et al.  A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells. , 2004, International immunology.

[92]  Guido Silvestri,et al.  Understanding the benign nature of SIV infection in natural hosts. , 2007, The Journal of clinical investigation.

[93]  S. Dooley,et al.  Roles of TGF-beta in hepatic fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[94]  D. Fairclough,et al.  Pirfenidone in idiopathic pulmonary fibrosis , 2010 .

[95]  J. Zeh,et al.  Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. , 1998, The Journal of infectious diseases.

[96]  Steven Wolinsky,et al.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis. , 2002, The Journal of clinical investigation.

[97]  O. Kirk,et al.  Factors associated with a reduced CD4 lymphocyte count response to HAART despite full viral suppression in the EuroSIDA study , 2003, HIV medicine.

[98]  M. Kobayashi,et al.  Direct contact between reticular fibers and migratory cells in the paracortex of mouse lymph nodes: a morphological and quantitative study. , 1988, Archives of histology and cytology.

[99]  T. Junt,et al.  Restoration of lymphoid organ integrity through the interaction of lymphoid tissue–inducer cells with stroma of the T cell zone , 2008, Nature Immunology.

[100]  J. Lisziewicz,et al.  T-cell receptor excision circles (TREC) in SHIV 89.6p and SIVmac251 models of HIV-1 infection. , 2004, DNA and cell biology.

[101]  J. Carlis,et al.  Cumulative mechanisms of lymphoid tissue fibrosis and T cell depletion in HIV-1 and SIV infections. , 2011, The Journal of clinical investigation.

[102]  Amiram Gafni,et al.  Highly Active Antiretroviral Therapy , 2012, PharmacoEconomics.

[103]  M. Miyasaka,et al.  Lymphocyte trafficking across high endothelial venules: dogmas and enigmas , 2004, Nature Reviews Immunology.

[104]  Thomas Lengauer,et al.  Risk Factors Associated with Older Age in Treatment-Naive HIV-Positive Patients , 2012, Intervirology.

[105]  Giota Touloumi,et al.  Effect of recent thymic emigrants on progression of HIV-1 disease , 2000, The Lancet.

[106]  Ronald N Germain,et al.  Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. , 2006, Immunity.

[107]  J. McCune,et al.  T cell turnover in HIV-1 disease. , 1997, Immunity.